Results 201 to 210 of about 291,487 (357)

Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes

, 2001
Teri Liegler, Matthew S. Hayden, Kok H. Lee, Rebecca Hoh, Steven G. Deeks, Robert M. Grant   +5 more
openalex   +1 more source

Evaluation of a single‐platform microcapillary flow cytometer for enumeration of absolute CD4+ T‐lymphocyte counts in HIV‐1 infected Thai patients [PDF]

, 2007
Kovit Pattanapanyasat, Yuwadee Phuang‐Ngern, Surada Lerdwana, Punneeporn Wasinrapee, Natthaga Sakulploy, Egarit Noulsri, Charin Thepthai, Janet M. McNicholl   +7 more
openalex   +1 more source

PLAUR+ Neutrophils Drive Anti‐PD‐1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment

Advanced Science, EarlyView.
The present study reveals that PLAUR+ neutrophils are enriched in immunotherapy non‐responders and correlate with poor prognosis. PLAUR+ neutrophils dictate immunotherapy resistance in hepatocellular carcinoma by forming an immunosuppressive tumor microenvironment characterized by CD8+ T cell exclusion and macrophage‐dependent immune suppression.
Shaoqing Liu, Yanzhao Zhou, Gaoxiang Li, Bingwen Zhu, Fang Wu, Jinxue Zhou, Xiaobing Chen, Bo Qin, Yanxia Gao, Fazhan Wang, Yong Jiang, Wenxin Xu   +11 more
wiley   +1 more source

Analysis of the clinical characteristics of poor immunological reconstitution in AIDS patients after long-term antiviral therapy in Xinjiang, China. [PDF]

BMC Immunol
Pan K, Wubuli M, Zhang T, Fan S, Lu X.
europepmc   +1 more source

CXCL13 Expression Promotes CAR T Cell Antitumor Activity and Potentiates Response to PD‐1 Blockade

Advanced Science, EarlyView.
This study demonstrates that engineering CAR T cells to express CXCL13 enhances their antitumor efficacy and significantly improves responsiveness to PD‐1 immune checkpoint blockade. CXCL13 promotes T cell persistence, and resistance to early exhaustion via the AKT‐mTOR pathway.
Yang Zhou, Wenli Zhao, Yihan Zhu, Hongyan Liu, Yicheng Sun, Zhengrong Gong, Xuanyi Li, Ziying Liu, Kang Wen, Yicheng Wang, Jie Ren, Ruipei Xiao, Ling Jiang, Yanfeng Hu, Enguang Bi, Xiaoyong Zhang   +15 more
wiley   +1 more source

Dynamic monitoring of lymphocyte subsets at different disease stages can predict the prognosis of acute myeloid leukemia especially in complete remission status. [PDF]

Sci Rep
Jiao X, Zhou J, Liang X, Zhu J, Xiao M, Ding Y, Tao Q, Xiao H, Li Y, Wang H, Zhai Z.   +10 more
europepmc   +1 more source

CD4 lymphocyte count in frail long term care elderly patients with eating difficulties

, 2002
Arthur Leibovitz, Lyly Blavat, Emily Lubart, Ahuva Sharon, Susane Feller, Beni Habot   +5 more
openalex   +1 more source

Lutetium‐Based Nanoprobes for Radiosensitization with Immune Microenvironment Remodeling and NIR‐II Fluorescence Imaging‐Guided Surgery in Colorectal Cancer

Advanced Science, EarlyView.
Enhancing radiosensitization, modulating the tumor immune microenvironment, and ensuring complete resection are crucial for colorectal cancer (CRC) treatment. This study presents a multifunctional NIR‐II fluorescent nanoprobe, RVLu@ICG, which enhances radiosensitization, remodels the tumor immune microenvironment, and enables precise image‐guided ...
Yongying Dang, Xianzhi Liu, Zifan Zheng, Ao Wang, Ying Huang, Zhong Luo, Haina Tian, Siyaqi Li, Qiang Luo, Peiyuan Wang, Weiling He   +10 more
wiley   +1 more source

Peripheral blood lymphocyte subsets of Chinese adults with liver steatosis. [PDF]

Sci Rep
Yan X, Li J, Wang Q, Xu T, Wu D.
europepmc   +1 more source

Relationship between Total Lymphocyte count (TLC) and CD4 count among peoples living with HIV, Southern Ethiopia: a retrospective evaluation [PDF]

, 2008
Deresse Daka, Eskindir Loha
openalex   +1 more source